Item 16. FORM 10-K SUMMARY
11K characters. Original on sec.gov · Markdown
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Dated: February 23, 2021 | Boston Scientific Corporation | |||||||||||||
| By: | /s/ Daniel J. Brennan | |||||||||||||
| Daniel J. Brennan | ||||||||||||||
| Executive Vice President and Chief Financial Officer | ||||||||||||||
| (duly authorized officer and principal financial officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Dated: February 23, 2021 | By: | /s/ Daniel J. Brennan | ||||||||||||
| Daniel J. Brennan | ||||||||||||||
| Executive Vice President and Chief Financial Officer | ||||||||||||||
| (Principal Financial Officer) |
| Dated: February 23, 2021 | By: | /s/ Michael F. Mahoney | ||||||||||||
| Michael F. Mahoney | ||||||||||||||
| Director, Chairman of the Board, President and Chief Executive Officer | ||||||||||||||
| (Principal Executive Officer) |
| Dated: February 23, 2021 | By: | /s/ Jonathan R. Monson | ||||||||||||
| Jonathan R. Monson | ||||||||||||||
| Vice President, Global Controller and Chief Accounting Officer | ||||||||||||||
| (Principal Accounting Officer) |
| Dated: February 23, 2021 | By: | /s/ Nelda J. Connors | ||||||||||||
| Nelda J. Connors | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Charles J. Dockendorff | ||||||||||||
| Charles J. Dockendorff | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Yoshiaki Fujimori | ||||||||||||
| Yoshiaki Fujimori | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Donna A. James | ||||||||||||
| Donna A. James | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Edward J. Ludwig | ||||||||||||
| Edward J. Ludwig | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Stephen P. MacMillan | ||||||||||||
| Stephen P. MacMillan | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ David J. Roux | ||||||||||||
| David J. Roux | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ John E. Sununu | ||||||||||||
| John E. Sununu | ||||||||||||||
| Director | ||||||||||||||
| Dated: February 23, 2021 | By: | /s/ Ellen M. Zane | ||||||||||||
| Ellen M. Zane | ||||||||||||||
| Director | ||||||||||||||
Schedule II
VALUATION AND QUALIFYING ACCOUNTS
(in millions)
| Description | Balance at Beginning of Year | Cumulative effect adjustment for adoption of ASU 2016-13 (a) | Credit loss exposure (a) | Write-offs (c) | Charges to (Deductions from) Other Accounts (d) | Balance at End of Year | |||||||||||||||||||||||||||||
| Year Ended December 31, 2020: | |||||||||||||||||||||||||||||||||||
| Allowances for credit losses (b) | $ | 74 | 10 | 49 | (27) | — | $ | 105 | |||||||||||||||||||||||||||
| Year Ended December 31, 2019: | |||||||||||||||||||||||||||||||||||
| Allowances for uncollectible accounts | $ | 68 | n/a | 23 | (17) | — | $ | 74 | |||||||||||||||||||||||||||
| Year Ended December 31, 2018: | |||||||||||||||||||||||||||||||||||
| Allowances for uncollectible accounts (e) | $ | 98 | n/a | 19 | (19) | (30) | $ | 68 |
(a) Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to Allowance for credit losses when we establish Trade accounts receivable if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on Trade accounts receivable and recorded a corresponding increase in the Allowance for credit losses, a contra Trade accounts receivable account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense.
(b) Beginning in 2020, Allowance for uncollectible accounts are referred to as Allowance for credit losses within our consolidated balance sheets.
(c) Represents actual write-offs of uncollectible accounts.
(d) Represents net change in allowances for sales returns, recorded as contra-revenue.
(e) Following the adoption of FASB ASC Topic 606 as of January 1, 2018, the allowance for sales returns has been reclassified from Trade accounts receivable, net to Other current liabilities within the consolidated balance sheets and is not included in the ending balance for 2018 above. Prior period balances remain unchanged.
Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES